Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy

'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.'

Go to News Site